Highlights & Chart Patterns of Dr. Reddy's Laboratories Ltd.
Long Term Support Line, Bottom Points : 4200.95/25-Jan-23 00:00 4077.35/16-Sep-22 00:00 4085.4/02-Aug-22 00:00
Long Term Support Line, Bottom Points : 4200.95/25-Jan-23 00:00 4077.35/16-Sep-22 00:00 4085.4/02-Aug-22 00:00
Long Term Support Line, Bottom Points : 4200.95/25-Jan-23 00:00 4077.35/16-Sep-22 00:00 4085.4/02-Aug-22 00:00
Bullish Crossover and sustaining.
Macd /Signal line bullish crossover and Zero line Cross over. Seems to be trending nicely
New High created.Possibility of breakout
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide
Share Price History of Dr. Reddy's Laboratories Ltd.
Date
Open
High
Low
Close
Volume
03-Feb-23
4375.00
4429.90
4318.20
4358.35
374 K
02-Feb-23
4313.00
4379.05
4291.55
4370.10
389 K
01-Feb-23
4341.00
4380.00
4310.25
4351.50
405 K
31-Jan-23
4345.00
4376.70
4293.30
4324.15
631 K
30-Jan-23
4319.95
4339.45
4284.95
4328.80
374 K
27-Jan-23
4280.00
4380.90
4253.35
4314.00
956 K
25-Jan-23
4260.00
4268.90
4175.10
4200.95
294 K
24-Jan-23
4341.00
4354.80
4237.00
4252.75
264 K
23-Jan-23
4359.95
4365.45
4319.35
4337.85
154 K
20-Jan-23
4331.95
4381.05
4280.00
4350.60
236 K
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick
TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential
TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback
We are working on fundamental strength also. Please share your views to help shape up the requirement.